BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 360302)

  • 1. Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw.
    Higgs EA; Moncada S; Vane JR
    Prostaglandins; 1978 Aug; 16(2):153-62. PubMed ID: 360302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGI2: a potential mediator of inflammation.
    Ford-Hutchinson AW; Walker JR; Davidson EM; Smith MJ
    Prostaglandins; 1978 Aug; 16(2):253-8. PubMed ID: 360303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperalgesic effects of prostacyclin and prostaglandin E2.
    Ferreira SH; Nakamura M; de Abreu Castro MS
    Prostaglandins; 1978 Jul; 16(1):31-7. PubMed ID: 360300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits.
    Armstrong JM; Lattimer N; Moncada S; Vane JR
    Br J Pharmacol; 1978 Jan; 62(1):125-30. PubMed ID: 339981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    Prostaglandins; 1978 Jun; 15(6):955-67. PubMed ID: 358297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activity of PGI2 and its metabolite 6-oxo-PGF1alpha on human uterus and fallopian tubes.
    Omini C; Pasargiklian R; Folco GC; Fano M; Berti F
    Prostaglandins; 1978 Jun; 15(6):1045-54. PubMed ID: 358294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
    Campos MM; Souza GE; Calixto JB
    Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual actions of prostacyclin (PGI2) on the rat pregnant uterus.
    Williams KI; El-Tahir KE; Marcinkiewicz E
    Prostaglandins; 1979 May; 17(5):667-72. PubMed ID: 386426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin (PG) modulation of bradykinin-induced hyperalgesia and oedema in the guinea-pig paw--effects of PGD2, PGE2 and PGI2.
    Whelan CJ; Head SA; Poll CT; Coleman RA
    Agents Actions Suppl; 1991; 32():107-11. PubMed ID: 2069078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral antialgesic action of aspirin-like drugs.
    Ferreira SH; Lorenzetti BB; CorrĂȘa FM
    Eur J Pharmacol; 1978 Dec; 53(1):39-48. PubMed ID: 310771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: a study on the paw edema induced in IP-receptor-deficient mice.
    Ueno A; Naraba H; Ikeda Y; Ushikubi F; Murata T; Narumiya S; Oh-ishi S
    Life Sci; 2000 Feb; 66(12):PL155-60. PubMed ID: 10737367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
    Campos MM; Calixto JB
    Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
    Francischi JN; Chaves CT; Moura AC; Lima AS; Rocha OA; Ferreira-Alves DL; Bakhle YS
    Br J Pharmacol; 2002 Nov; 137(6):837-44. PubMed ID: 12411415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromoenol Lactone, an Inhibitor of Calcium-Independent Phospholipase A2, Suppresses Carrageenan-Induced Prostaglandin Production and Hyperalgesia in Rat Hind Paw.
    Tsuchida K; Ibuki T; Matsumura K
    Mediators Inflamm; 2015; 2015():605727. PubMed ID: 26063975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK; Heidemann HT; Branch RA; Gerkens JF
    Circ Res; 1982 Jul; 51(1):67-72. PubMed ID: 7044603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist.
    de Campos RO; Alves RV; Ferreira J; Kyle DJ; Chakravarty S; Mavunkel BJ; Calixto JB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):278-86. PubMed ID: 10543429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.